Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Brimosopt 0.2% Eye Drop

Brimosopt 0.2% Eye Drop

NAFDAC Reg. No. A4-101222 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 6 November 2026 · synced automatically from official sources.
Producto
Brimosopt 0.2% Eye Drop
Número NAFDAC
A4-101222
Principio activo
Brimonidine Tartrate
Dosis
0.2%
Forma
Colirio
Tamaño del envase
1 x 10 mL (in sterile plastic vial)
Fabricante
No Constan
Solicitante (titular)
NCI PharmChem Industries Limited
Approved
27 Mar 2025
Estado
Activo Ver en NAFDAC ↗
Registro válido hasta
26 Mar 2030
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Brimonidine tartrate: uses, dosage and brands worldwide

Lo que encontramos

  • Brimosopt 0.2% Eye Drop is on the NAFDAC register with an active registration (A4-101222). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Brimosopt 0.2% Eye Drop

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Relieves redness of the eye due to minor eye irritations

Cómo tomarlo y con qué frecuencia
  • Adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours
  • Do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch tip of container to any surface replace cap after each use
  • Children under 5 years of age: consult a doctor
Talk to a doctor first if

you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days

Warnings

For external use only Do not use if solution changes color or becomes cloudy Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Pregnancy and breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

How to store it

Keep out of reach of children.

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-03-31.

Label for brimonidine tartrate, the active ingredient registered with NAFDAC.

Check your pack of Brimosopt 0.2% Eye Drop

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Brimosopt 0.2% Eye Drop

What is in Brimosopt 0.2% Eye Drop?

Brimosopt 0.2% Eye Drop contains Brimonidine Tartrate (0.2%), as eye drops, according to its NAFDAC registration record.

Is Brimosopt 0.2% Eye Drop registered with NAFDAC?

Yes. Brimosopt 0.2% Eye Drop is listed on the NAFDAC register under registration number A4-101222, and its registration is active as of 6 November 2026.

Has Brimosopt 0.2% Eye Drop been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Brimosopt 0.2% Eye Drop in our automatically synced alert list.

How can I check that my pack of Brimosopt 0.2% Eye Drop is genuine?

Run a free authenticity scan with the NAFDAC number A4-101222, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Brimosopt 0.2% Eye Drop?

Follow your prescription or the leaflet in your pack. The official label says: adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch …

What is Brimosopt 0.2% Eye Drop used for?

relieves redness of the eye due to minor eye irritations (Summarised from the official U.S. FDA label for brimonidine tartrate. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Brimosopt 0.2% Eye Drop? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.